(NYSE: CNMD) Conmed's forecast annual revenue growth rate of 8.77% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Conmed's revenue in 2024 is $1,244,744,000.On average, 5 Wall Street analysts forecast CNMD's revenue for 2024 to be $41,508,087,089, with the lowest CNMD revenue forecast at $41,365,080,574, and the highest CNMD revenue forecast at $41,630,716,868. On average, 5 Wall Street analysts forecast CNMD's revenue for 2025 to be $45,162,417,564, with the lowest CNMD revenue forecast at $44,386,808,837, and the highest CNMD revenue forecast at $45,613,722,237.
In 2026, CNMD is forecast to generate $49,403,979,697 in revenue, with the lowest revenue forecast at $47,658,475,303 and the highest revenue forecast at $50,923,370,045.